KR101070382B1 - Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it - Google Patents

Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it Download PDF

Info

Publication number
KR101070382B1
KR101070382B1 KR1020080106031A KR20080106031A KR101070382B1 KR 101070382 B1 KR101070382 B1 KR 101070382B1 KR 1020080106031 A KR1020080106031 A KR 1020080106031A KR 20080106031 A KR20080106031 A KR 20080106031A KR 101070382 B1 KR101070382 B1 KR 101070382B1
Authority
KR
South Korea
Prior art keywords
jujube
soap
extract
jujube seed
ethanol
Prior art date
Application number
KR1020080106031A
Other languages
Korean (ko)
Other versions
KR20100046968A (en
Inventor
박준홍
장은영
박은주
이순이
김미경
장정현
이강태
이형백
Original Assignee
박준홍
장은영
박은주
이순이
주식회사 정문
장정현
이강태
이형백
김미경
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박준홍, 장은영, 박은주, 이순이, 주식회사 정문, 장정현, 이강태, 이형백, 김미경 filed Critical 박준홍
Priority to KR1020080106031A priority Critical patent/KR101070382B1/en
Publication of KR20100046968A publication Critical patent/KR20100046968A/en
Application granted granted Critical
Publication of KR101070382B1 publication Critical patent/KR101070382B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D13/00Making of soap or soap solutions in general; Apparatus therefor
    • C11D13/10Mixing; Kneading
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D9/00Compositions of detergents based essentially on soap
    • C11D9/04Compositions of detergents based essentially on soap containing compounding ingredients other than soaps
    • C11D9/22Organic compounds, e.g. vitamins
    • C11D9/38Products in which the composition is not well defined
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 대추씨 추출물을 이용한 비누 및 그 제조 방법에 관한 것으로, 대추씨의 에탄올 추출물을 감압 농축시킨 대추씨 추출물 농축액이 총중량의 0.5-10중량% 첨가되는 비누와 그 제조방법을 제공하여, 대추씨를 재사용하도록 하면서 물에 비하여 세포막투과성이 우수한 에탄올을 이용하여 추출액을 얻고, 농축액을 사용하므로, 대추씨의 유효성분 첨가량을 증가시키고 피부 침투율을 향상시켜 우수한 피부개선효과를 얻을 수 있도록 하는 것이다.The present invention relates to a soap using a jujube seed extract and a method for manufacturing the same, and to provide a soap and a method for producing the jujube seed extract concentrate, which is concentrated under reduced pressure of the ethanol extract of jujube seed, in a total weight of 0.5-10% by weight, While reusing seeds, the extract is obtained using ethanol having excellent cell membrane permeability compared to water, and the concentrate is used, thereby increasing the amount of active ingredient added to the jujube seed and improving skin penetration rate to obtain an excellent skin improvement effect.

대추씨, 에탄올, 비누 Jujube seed, ethanol, soap

Description

대추씨 추출물을 이용한 비누 및 그 제조 방법{Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it}Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it}

본 발명은 대추씨 추출물을 이용한 비누 및 그 제조 방법에 관한 것으로, 보다 상세하게는 사용되지 않고 버려지는 대추씨에서 유효성분을 에탄올을 이용하여 추출하여, 버려지는 대추씨를 재사용하고, 대추씨의 유효성분으로 인한 피부 개선 효과와 에탄올의 사용으로 인한 세포막투과성 향상 효과를 얻을 수 있는 대추씨 추출물을 이용한 비누 및 그 제조 방법에 관한 것이다.The present invention relates to a soap using a jujube seed extract and a method for producing the same, and more particularly, extracts the active ingredient from ethanol discarded without being used, using ethanol to reuse the discarded jujube seed, effective of jujube seed The present invention relates to a soap using a jujube seed extract and a method for producing the same, which can obtain a skin improving effect due to an ingredient and a cell membrane permeability improving effect due to the use of ethanol.

대추에는 비타민, 아미노산, 사과산, 호박산 등과 같은 유기산이 약 0.55 ∼ 3.5% 함유되어 있으며, 비타민A, B2, C, P 등이 다양하게 함유되어 있다. Jujube contains about 0.55 to 3.5% of organic acids such as vitamins, amino acids, malic acid, succinic acid, etc., and contains various vitamins A, B2, C, and P.

그리고 한방에서는 말린 대추를 달여 먹으면 몸이 훈훈해질 뿐만 아니라 피부를 윤택 하게 하는 미용작용, 양혈하고 정신을 안정시키며 각종 약독을 해독시키는 효능 및 항알레르기 작용 등 여러 가지의 질병 치료효과가 있는 것으로 알려져 있으며, 특히 대추에는 대량의 비타민 C와 미량원소가 함유돼 있어 늘 복용하면 피부를 매끈하고 깨끗하게 하며 혈색이 건강하고 얼굴을 아름답게 하는 등의 효과가 있다고 알려져 있다.In oriental medicine, the dried jujube is known to be effective in treating various diseases such as not only warming the body but also nourishing the skin, bleeding, stabilizing the mind, detoxifying various poisons, and anti-allergic effects. In particular, jujube is known to contain a large amount of vitamin C and trace elements, so that when taken regularly, the skin is smooth and clean, the color is healthy, and the face is beautiful.

이러한 대추는 통상 씨를 제거한 과육을 이용하여 죽, 차, 떡, 약밥 등에 사용하거나, 최근에는 대추음료, 액상대추차, 과립대추차, 대추과당, 대추시럽 등의 여러 가공형태로 이용되고 있다.Such jujube is usually used in porridge, tea, rice cake, medicine rice, etc. by using the flesh from which seeds are removed, or recently, it is used in various processing forms such as jujube drink, liquid jujube tea, granulated jujube tea, jujube fructose, jujube syrup.

그리고 상기한 대추의 이용과 관련하여 대추추출물을 이용한 기술이 다수 공개되어 있으며, 그 예로서 대한민국 특허번호 제0583051호 “암 치료 및 예방을 위한 계피 및 대추 추출물”에서는 계피 및 대추 추출물을 포함하는 암치료 및 예방용 약학적 조성물 및 기능성 식품에 관한 것으로 각각의 구성성분에 의한 세포 사멸 및 암세포 이동을 억제하는 효과와 구성성분의 혼합에 의해 암세포 성장억제 효과의 상승에 관해 개시한 바 있고, 대한민국공개번호 제99-0039367호에는 “대추 추출물을 포함하는 혈압 강하용 조성물”에서는 대추 추출물을 포함하여 혈압을 강하시키는 고혈압 치료제 또는 건강식품의 성분에 관해 개시한 바 있으며, 대한민국 공개특허 10-2008-0080719호에는 대추를 증류수를 이용하여 원심분리 후 에탄올을 이용하여 추출하여 비누로 제조하는 방법이 공개되어 있다.In addition, a number of techniques using jujube extract have been disclosed in connection with the use of the jujube. For example, Korean Patent No. 0583051 “Cinnamon and Jujube Extract for Cancer Treatment and Prevention” includes cancers including cinnamon and jujube extract. The present invention relates to pharmaceutical compositions and functional foods for treatment and prophylaxis, and discloses the effect of inhibiting cell death and cancer cell migration by each component and the increase of cancer cell growth inhibitory effect by mixing the components. No. 99-0039367 discloses the composition of the antihypertensive agent or health food for lowering blood pressure, including the jujube extract, in the “composition for lowering blood pressure comprising jujube extract”, Republic of Korea Patent Publication No. 10-2008-0080719 In the lake, jujube was centrifuged with distilled water, extracted with ethanol, and washed with soap. Methods of making are disclosed.

이와 같이 종래의 대추를 이용한 가공 식품 및 각종 선행기술들이 과육을 위주로 사용하거나 전체를 사용하는 것으로, 가공식품 등에 사용된 후 버려지는 씨에 대한 이용 방법은 제시하지 않고 있다.As described above, processed foods using various jujubes and various prior arts mainly use the pulp or use the whole, and do not present a method of using the seed discarded after being used in processed foods.

한편, 본 발명의 출원인이 선출원하여 등록한 대한민국 등록특허 10-0801902호에 물이나 메탄올을 이용하여 대추씨로부터 유효성분을 추출한 것이 항암, 항산화작용이 있어서, 이를 식품이나 의약품으로 사용하는 기술이 공개되어 있다.On the other hand, the Republic of Korea Patent No. 10-0801902 registered and filed by the applicant of the present invention to extract the active ingredient from the jujube seed using water or methanol has an anti-cancer, antioxidant action, the technology to use it as a food or medicine is disclosed have.

그러나 상기한 선행기술은 식품이나 의약품 등 섭취되는 제품의 사용에만 그 사용방법이 제한되어 있으며, 메탄올과 증류수를 이용한 추출로 국한되어 있는데, 특히, 메탄올은 세포막투과성이 우수하여 피부를 통해서도 유입될 수 있으며 이 경로를 통해 치명적인 증상이 발생했다는 보고가 있고, 증상은 "흡입"으로 인한 증상과 유사하다. 이러한 메탄올은 접촉시 가벼운 피부 가려움증, 건조 및 갈라짐을 유발하고, 경미하거나 가벼운 안구 자극을 유발하며, 섭취시 실명 또는 사망에 이를 수 있으며 치사량 미만의 메탄올 섭취는 구토, 두통, 복부 통증, 구토와 흐린 시야와 빛에 민감해지는 증상을 유발할 수 있고, 흡입이나 피부노출을 통한 메탄올 장기(만성) 노출시 신경계 중독, 두뇌 장애, 시각 장애 및 실명을 유발할 수 있다. 한편, 물은 메탄올에 비하여 세포막투과성이 낮은 문제점이 있었다.However, the above-described prior art is limited to the use of ingested products such as foods and medicines, and is limited to extraction using methanol and distilled water. In particular, methanol has excellent cell membrane permeability and can be introduced through the skin. It has been reported that fatal symptoms have occurred through this pathway, and the symptoms are similar to those caused by "inhalation." These methanol causes mild skin itching, dryness and cracking on contact, cause minor or mild eye irritation, blindness or death upon ingestion, and ingestion of methanol below lethal doses may cause vomiting, headache, abdominal pain, vomiting and cloudy May cause symptoms that are sensitive to vision and light, and may cause nervous system intoxication, brain disorders, blindness and blindness when exposed to methanol (chronic) exposure through inhalation or skin exposure. On the other hand, water has a problem of low cell membrane permeability compared to methanol.

본 발명은 종래 대추를 이용한 가공식품에서 버려지는 대추씨를 재사용하도록 하면서 물에 비하여 세포막투과성이 우수한 에탄올을 이용하여 추출액을 얻고, 농축액을 사용하므로, 대추씨의 유효성분 첨가량을 증가시키고 피부 침투율을 향상시켜 우수한 피부개선효과를 얻을 수 있도록 하는 데에 목적이 있다.The present invention obtains the extract using ethanol excellent in cell membrane permeability compared to water while reusing the jujube seed discarded in processed foods using conventional jujube, and using the concentrate, increase the amount of active ingredient added to the jujube seed and improve skin penetration rate The purpose is to achieve excellent skin improvement effect.

상기한 목적을 달성하기 위한 본 발명의 특징은, 대추씨의 에탄올 추출물을 감압 농축시킨 대추씨 추출물 농축액이 총중량의 0.5-10중량% 첨가되는 것을 특징으로 하는 비누에 있다.A feature of the present invention for achieving the above object is a soap, characterized in that the addition of 0.5-10% by weight of the total weight of the jujube extract extract concentrated under reduced pressure concentrated ethanol extract of jujube seed.

그리고 본 발명의 다른 특징은 대추씨의 분말시료에 5-15배의 99% 에탄올을 첨가한 후 환류 냉각기를 설치한 수욕 상에서 5-10시간 동안 1-5회 반복 추출한 후 여과하고, 이 여액들을 감압 농축시키는 대추씨 추출물 농축액 준비 단계와, 상기한 대추씨 추출물 농축액을 총중량의 0.5-10중량%가 되도록 첨가하여 비누를 제조하는 비누 제조단계로 구성되는 비누 제조방법에 있다.And another feature of the present invention is to add 5-15 times 99% ethanol to the jujube seed powder sample and repeated 1-5 times extraction for 5-10 hours in a water bath equipped with a reflux cooler and then filtered the filtrate A jujube seed extract concentrate is prepared by concentrating under reduced pressure, and the soap production method includes a soap manufacturing step of preparing a soap by adding the above jujube seed extract concentrate to 0.5-10% by weight of the total weight.

본 발명에서는 통상의 식품으로 제조되는 가공품에서 사용되지 않고 버려지는 대추씨를 재사용하므로 자원재활용 효과와 함께 소득 개선 효과를 얻을 수 있도록한다.In the present invention, since the jujube seed is discarded without being used in processed foods manufactured with ordinary food, it is possible to obtain an income improvement effect along with a resource recycling effect.

그리고 물에 비하여 세포막투과성이 우수한 에탄올을 이용하여 추출액을 얻 고 농축액을 사용하므로, 비누에 포함되는 대추씨의 유효성분 첨가량이 비농축액을 사용한 것과 비교하여 증가되고, 세포막투과성이 우수한 에탄올을 이용하므로 종래의 물을 이용한 추출액에 비하여 피부 침투율이 개선되어, 피부개선효과를 얻을 수 있다.In addition, since the extract is obtained using ethanol having excellent cell membrane permeability compared to water, and the concentrate is used, the amount of active ingredient added to the jujube seed included in the soap is increased compared to the case of using the non-concentrate, and thus the ethanol having excellent cell membrane permeability is used. Compared with the conventional extract using water, the skin penetration rate is improved, and the skin improvement effect can be obtained.

아울러, 세포막투과성이 우수한 메탄올의 경우 피부에 문제를 야기하나, 상기한 에탄올을 이용한 추출의 경우 피부에 전혀 문제를 일으키지 않고, 소독효과와 우수한 세포막투과성이 있으므로 피부개선에 도움이 된다.In addition, methanol having excellent cell membrane permeability causes a problem on the skin, but the above-mentioned extraction using ethanol does not cause any problem on the skin, and it is helpful for skin improvement because of its disinfection effect and excellent cell membrane permeability.

또한, 상기한 대추씨 추출물은 항암, 항산화효능이 있으므로, 이러한 유효성분에 의하여 피부가 개선되는 효과가 있다.In addition, the above jujube seed extract has anti-cancer, anti-oxidant effect, thereby improving the skin by such an active ingredient.

아울러, 에탄올은 지방산과 수산화칼륨의 화학반응 속도를 증가시키므로 비누의 제조시에 제조시간을 단축할 수 있는 효과가 있다.In addition, ethanol increases the chemical reaction rate of the fatty acid and potassium hydroxide has the effect of reducing the manufacturing time during the production of soap.

이하 본 발명의 실시예를 보다 구체적으로 살펴본다.Hereinafter, an embodiment of the present invention will be described in more detail.

1. 대추씨 추출물 추출1. Jujube Seed Extract Extract

본 실험에 사용한 대추(Ziziphus jujube)는 경상북도 경산지역에서 재배된 것으로 과육과 대추씨를 분리하여 건조시킨 후 분쇄기로 분말화하였다.Jujube ( Ziziphus jujube ) used in this experiment was cultivated in Gyeongsan, Gyeongsangbuk-do.

대추과육과 대추씨의 분말시료에 10배의 99% 에탄올을 첨가한 후 환류 냉각기를 설치한 수욕 상에서 8시간 동안 3회 반복 추출한 후 여과하였다. 이 여액들을 감압 농축시켜 에탄올 추출물로 사용하였다.After adding 10 times 99% ethanol to the jujube flesh and jujube seed powder samples, the extract was filtered three times for 8 hours in a water bath equipped with a reflux condenser and filtered. The filtrates were concentrated under reduced pressure and used as an ethanol extract.

이 시료들은 -30℃에 보관하면서 실험에 사용하였다.These samples were used for the experiment while stored at -30 ℃.

2. 비누 제조2. soap manufacturer

비누 제조방법은 MP(melt and pour)법, CP(cold process)법, HP(hot process)법, 리배칭(Rebacthing)법 등이 이미 알려져 있으며, 이러한 방법 중 어느 하나를 사용하더라도 무방하며, 대추씨 추출물 농축액의 첨가량은 비누 1kg을 만들 때 5g-100g을 첨가한다.The soap manufacturing method is known as the MP (melt and pour) method, CP (cold process) method, HP (hot process) method, Rebatch (Rebacthing) method, etc., any of these methods may be used, jujube The amount of seed extract concentrate added is 5g-100g when making 1kg soap.

비누 제조방법의 일 실시 예를 살펴본다.Look at one embodiment of a soap manufacturing method.

제1단계: 비누에 사용되는 지방산유지는 이미 여러 가지가 알려져 있어서, 제조하고자 하는 목적에 따라 표 1에 나타내는 지방산유지를 선택하여 사용한다.Step 1: Fatty acid oils used in soaps are already known, and according to the purpose to be prepared, the fatty acid fats shown in Table 1 are selected and used.

그 예로는 100%의 중량비로 올리브오일 40-60%와, 코코넛오일 60-40%를 혼합하여 사용할 수도 있다.For example, 40-60% olive oil and 60-40% coconut oil may be used in a weight ratio of 100%.

Figure 112008074905591-pat00001
Figure 112008074905591-pat00001

제2단계: 중량비로 가성소다 20-35%와 정제수 65-80%를 혼합하여 화학결합시키고, 이를 상온에서 식혀 25-43℃로 유지시키는 단계를 거치되, 정제수에 가성소다를 투입한다. Second step: 20-35% caustic soda and 65-80% of purified water are mixed by weight, followed by a step of cooling the mixture at room temperature and maintaining it at 25-43 ° C, and adding caustic soda to purified water.

제3단계: 상기 지방산유지를 교반시키되, 40-50℃가 될 때까지 약한 불로 가열하며 교반한다.Third step: While maintaining the fatty acid, stirring while heating over low heat until 40-50 ℃.

제4단계: 상기 교반된 지방산유지를 40-70중량%로 투입하고, 이에 상기 가성소다와 정제수의 혼합액을 30-60중량%로 투입하되, 온도는 40-50℃로 유지하고 천천히 부으면서 교반시키는 단계를 거친다. Step 4: The stirred fatty acid oil is added at 40-70% by weight, and the mixture of caustic soda and purified water is added at 30-60% by weight, but the temperature is maintained at 40-50 ° C. and slowly poured while stirring. Go through the steps

제5단계: 상기 교반물에 교반물 대비 2-6중량%의 대추씨 추출물을 투입하여 교반시키는 단계를 거친다.Step 5: Injecting 2-6% by weight of the jujube seed extract compared to the agitated mixture to the agitated mixture.

이와 같이 교반된 비누액을 몰드에 넣어서 경화시킨다.The soap solution stirred in this way is put into a mold and cured.

그리고 비누제조방법의 2실시예를 살펴보면, 비누베이스1kg, 올리브오일15g, 글리세린 15g, 에센셜오일10g, 대추씨 추출물 농축액30g, 무수에탄올을 준비한다.Looking at the second embodiment of the soap manufacturing method, 1kg soap base, 15g olive oil, 15g glycerin, 10g essential oil, 30g jujube seed extract concentrate, anhydrous ethanol is prepared.

비누베이스를 작게 잘라 비이커에 넣고 핫플레이트(전자렌지)를 이용해 녹여준 후, 계량해놓은 첨가제(올리브오일, 글리세린, 대추씨 추출물 농축액)와 비누베이스 녹인것을 혼합하여 잘 저어준다.Cut a small amount of soap base into a beaker and melt it using a hot plate (microwave), then stir well by mixing the weighed additives (olive oil, glycerin, jujube seed extract concentrate) with the soap base.

잘 섞은 비누액의 온도가 45-50℃로 내려가면 마지막으로 에센셜오일을 넣고 저어준 후, 비누액의 온도가 45-50도 유지하도록 하면서 몰드에 비누액을 붓는다.When the temperature of the well-mixed soap liquid is lowered to 45-50 ℃, add essential oil and stir, and then pour the soap liquid into the mold while maintaining the temperature of the soap liquid at 45-50 degrees.

비누액을 비누몰드에 붓고 난 후 표면에 거품이 생기면 무수에탄올을 살짝 뿌려준다.After the soap is poured into the soap mold, if the surface bubbles, sprinkle a little ethanol.

상온에서 비누 굳으면 몰드에서 비누를 꺼낸다.When soap solidifies at room temperature, remove the soap from the mold.

이와 같이 제조된 비누는 도 1에 나타내는 바와 같이 투명한 갈색을 갖는다.The soap thus produced has a transparent brown color as shown in FIG. 1.

3. 대추씨추출물의 효능실험3. Efficacy test of jujube seed extract

(1) 대추씨추출물 농축액은 상기한 에탄올 추출 후 농축한 것을 사용한다.(1) As the jujube seed extract concentrate, the concentrated ethanol extract was used.

(2) 시 약 (2) reagent

벤조피렌(Benzo(a)pyrene), 4-니트로퀴놀린-1-옥사이드(4-nitroquinoline-1-oxide), 니코틴아미드 아데닌 뉴클레오티드 인산(NADP), 환원형 니코틴아미드아데닌디뉴클레오티드인산(NADPH), D-글루코스-6-포스페이트(D-glucose-6-phosphate), 차아황상나트륨(sodium dithionite), 아크릴아미드(acrylamide), TEMED(N, N, N’, N’-tetra methyl ethylene diamine), 소 혈청 알부민(bovine serum albumin), 피로갈롤(Pyrogallol), 글루타티온(glutathione) (reduced), SDS 등은 Sigma사(USA)로부터, D-비오틴(D-biotin)과 L-히스티딘(L-histidine) 등은 Junsei Chemical Co.(Japan) 제품을 사용하였다. 그리고 N-메틸-N-니트로소-구아니딘(N-methyl-N-nitro-N-nitroso-guanidine)(MNNG)는 Aldrich Chemical Co.(USA)로부터, aroclor 1254는 Chem. Lite사(German)로부터, immobilon PVDF membrane, ECL detection kit는 NENTM Life Science사(USA)로부터 구입하였고, polyclonal antibody Anti-rat CYP1A1(goat)은 DAIICHI Pure chemicals사(Japan)로부터 구입하여 사용하였으며, DMEM, FBS, penicillin G/streptomycin은 Gibco사 (USA)에서 구입하였으며 그 밖의 시약들도 특급 제품을 사용하였다.Benzo (a) pyrene, 4-nitroquinoline-1-oxide, nicotinamide adenine nucleotide phosphoric acid (NADP), reduced nicotinamide adenine dinucleotide phosphoric acid (NADPH), D- D-glucose-6-phosphate, sodium dithionite, acrylamide, TEMED (N, N, N ', N'-tetra methyl ethylene diamine), bovine serum albumin (bovine serum albumin), pyrogallol, glutathione (reduced), SDS, etc. from Sigma (USA), D-biotin and L-histidine, etc., Junsei Chemical Co. (Japan) product was used. And N-methyl-N-nitro-N-nitroso-guanidine (MNNG) from Aldrich Chemical Co. (USA), aroclor 1254 from Chem. The immobilon PVDF membrane, ECL detection kit was purchased from Lite (German) from NEN TM Life Sciences (USA), and the polyclonal antibody Anti-rat CYP1A1 (goat) was purchased from DAIICHI Pure Chemicals (Japan). DMEM, FBS, and penicillin G / streptomycin were purchased from Gibco (USA), and other reagents were used as express products.

(3) 항산화 실험(3) antioxidant experiment

추출물의 DPPH(1.1-diphenyl-2-picrylhydrazyl) 라디칼 소거능은 요시가와(Yoshikawa) 등의 방법에 의해 다음과 같이 측정하였다. DPPH (1.1-diphenyl-2-picrylhydrazyl) radical scavenging ability of the extract was measured by Yoshikawa et al.

0.1M의 초산 완충액(pH 5.5)에 시료 및 0.2mM DPPH 용액을 가하여 10초간 진탕한 후 37℃에서 30분간 반응시킨 다음, 이 반응액을 분광광도계(Spectronic GENESYS 5, MILTON ROY)를 사용하여 517nm에서 흡광도를 측정하였으며, 그 결과는 도 1과 같다.Samples and 0.2 mM DPPH solution were added to 0.1 M acetate buffer (pH 5.5), shaken for 10 seconds, and reacted for 30 minutes at 37 ° C. The reaction solution was then 517 nm using a spectrophotometer (Spectronic GENESYS 5, MILTON ROY). Absorbance was measured at, and the results are shown in FIG. 1.

(4) 항돌연변이 실험(4) antimutagenic experiment

시료 추출물의 항돌연변이 효과는 Ames의 mutagenicity test를 이용하여 검토하였으며, 여기에 사용된 균주는 Salmonella typhimuriumTA98과 TA100은 미국 California대학 (Berkeley)의 Bruce N. Ames 박사로부터 제공받아 정기적으로 histidine 요구성, deep rough(rfa)돌연변이, uvrB 돌연변이, R-factor 등의 유전형질을 확인하면서 실험균주로 사용하였다. 이들 균주의 genotype은 표 2와 같다.The antimutagenic effect of the sample extract was examined using the Ames mutagenicity test. The strains used were Salmonella typhimurium TA98 and TA100 from Dr. Bruce N. Ames of the University of California, Berkeley. Genetic strains such as deep rough (rfa) mutation, uvrB mutation, and R-factor were used as experimental strains. The genotypes of these strains are shown in Table 2.

그리고 Salmonella typhimurium TA98과 TA100균주는 정기적으로 histidine 요구성, deep rough (rfa) 돌연변이, uvrB 돌연변이, R fator 등의 유전형질을 확인한 후 실험 균주로 사용하였다. Salmonella typhimurium TA98 and TA100 strains were routinely identified as genotypes such as histidine requirements, deep rough ( rfa ) mutations, uvrB mutations, and R fator .

돌연변이 유발요인(Mutagens)과 발암물질(Carcinogens)을 살펴보면, 간접 돌연변이 유발요인(Indirect mutagens)으로 Benzo(a)pyrene(B(a)P)은 DMSO에 녹여 실험에 사용하였다. 그리고, 직접 돌연변이 유발요인(Direct mutagens)으로는 N-methyl-N'-nitro-N-nitrosoguanidine(MNNG)와 4-nitroquinoline-1 -oxide(4-NQO)는 증류수와 DMSO에 녹여 실험하였다.Mutogens and carcinogens were examined. Benzo (a) pyrene (B (a) P) was used as an indirect mutagens in DMSO. Direct mutagens were tested by dissolving N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and 4-nitroquinoline-1 -oxide (4-NQO) in distilled water and DMSO.

S9 mixture는 동물의 체내 대사활성계를 이용하여 간접돌연변이유발요인을 활성화시키기 위해서 Maron과 Ames의 방법에 따라 조제한 간의 microsomal enzyme mixture이다. 대한실험동물사로부터 구입한 체중 약 200g의 Sprague-Dawley 수컷 흰쥐의 microsomal enzyme을 유도하기 위해 polychlorinated biphenyl(PCB) mixture인 aroclor 1254를 corn oil로 희석하여 복강내로 1회 주사(500mg/kg)한 다음 5일 후에 간을 적출하였다. 적출한 간은 무균 상태에서 빙냉의 0.15M KCl용액으로 세척한 다음 간 g당 0.15M KCl 3㎖를 첨가하여 멸균된 가위로 세절한 후 homogenizer로 균질화 시켰다. 이것을 9,000×g, 4℃에서 10분간 원심분리하여 상징액인 S9 fraction을 얻었다. 이 fraction을 1.5㎖씩 cryogenic vial에 분주하여 급속 동결한 후 -80℃에 보관하였다. S9 mixture는 S9 fraction(10%)을 MgCl-KCl salts(2%), 1M glucose-6-phosphate(0.5%), 1M NADP(4%), 0.2M phosphate buffer(pH7.4)와 멸균수를 혼합하여 조제하였다.S9 mixture is a liver microsomal enzyme mixture prepared according to the method of Maron and Ames in order to activate the indirect mutagenesis factor using the metabolic activity system of the animal. In order to induce microsomal enzyme from Sprague-Dawley male rats weighing about 200 g from Korean experimental animals, aroclor 1254, a polychlorinated biphenyl (PCB) mixture, was diluted with corn oil and injected once intraperitoneally (500 mg / kg). After 5 days the livers were removed. The extracted liver was washed with ice-cooled 0.15M KCl solution in sterile state, and then added with 3ml of 0.15M KCl per gram of liver, chopped with sterile scissors and homogenized with a homogenizer. This was centrifuged at 9,000 × g and 4 ° C. for 10 minutes to obtain a S9 fraction as a supernatant. 1.5 mL of this fraction was dispensed into cryogenic vials and rapidly frozen and stored at -80 ° C. The S9 mixture contains S9 fraction (10%) with MgCl-KCl salts (2%), 1M glucose-6-phosphate (0.5%), 1M NADP (4%), 0.2M phosphate buffer (pH7.4) and sterile water. The mixture was prepared.

그리고, Maron과 Ames, Matsushima 등의 방법을 이용하여 시료와 변이원의 돌연변이성과 항돌연변이성을 preincubation mutagenicity test로 검토하였다.The mutagenicity and antimutagenicity of samples and mutagen were examined by preincubation mutagenicity test using methods such as Maron, Ames and Matsushima.

상기한 Preincubation mutagenicity test는 S9 mixture 0.5㎖ (간접돌연변이원) 혹은 phosphate buffer 0.5㎖ (직접돌연변이원), 12시간 배양된 균주 0.1㎖, 시료 50㎕, mutagen 50㎕를 ice bath에 담긴 cap tube에 첨가하여 가볍게 섞은 다음 37℃에서 30분간 예비 배양한 후 45℃의 top agar 2㎖씩을 각 tube에 첨가하고 3초간 혼합하였다. 이것을 minimal glucose agar plate에 도말하고 37℃에서 48시간 배양한 후 revertant colony 숫자를 계수하였다.In the preincubation mutagenicity test, 0.5 ml of S9 mixture (indirect mutation) or 0.5 ml of phosphate buffer (direct mutation), 0.1 ml of strain incubated for 12 hours, 50 µl of sample, and 50 µl of mutagen were added to the cap tube containing ice bath. After mixing lightly and pre-incubated at 37 ° C. for 30 minutes, 2 ml of top agar at 45 ° C. was added to each tube and mixed for 3 seconds. This was plated on a minimal glucose agar plate and incubated at 37 ° C. for 48 hours to count the number of revertant colonies.

한편 실험에 사용된 시료와 돌연변이 유발물질의 농도는 예비 실험 (dose response 및 독성실험)을 통하여 결정하였다. Meanwhile, the concentrations of the sample and mutagen used in the experiment were determined through preliminary experiments (dose response and toxicity experiment).

돌연변이 저해율(Inhibition rate)은 아래 수학식 1에 의해 계산하였다.Inhibition rate was calculated by Equation 1 below.

Inhibition rate(%) =[(a-b)/(a-c)]×100Inhibition rate (%) = [(a-b) / (a-c)] × 100

a : 돌연변이원에 의해 유도된 복귀 돌연변이수a: number of return mutations induced by the mutagen

b : 시료를 처리하였을 때의 복귀 돌연변이수 b: number of return mutations when the sample is processed

c : 돌연변이원과 시료가 없을 경우의 자연복귀 돌연변이수c: Natural return mutations without mutagen and sample

대추씨 추출물을 Salmonella typhimurium TA100에 N-methyl-N`-nitro-nitroso-gaunidine를 이용한 항돌연변이 효과를 표 2에 나타내고, 대추씨 추출물을 Salmonella typhimurium TA100에 4-nitroquinoline1-oxide을 이용한 항돌연변이 효과를 표 3에 나타내며, 대추 에탄올추출물을 Salmonella typhimurium TA98에 benzo(a)pyrene을 이용한 간접돌연변이 효과를 표 4에 나타내며, 대추의 돌연변이 억제효과를 Ames test로 검색한 결과 대추 추출물들 자체의 돌연변이원성은 없었으 며 직접변이원인 N-methyl-N'-nitro-N-nitrosoguanidine와 4-nitro-quinoline-1-oxide 그리고 간접변이원인 benzo(a)pyrene 에 대해서 돌연변이 억제 효과를 나타내었다. A date palm seed extract the S almonella typhimurium TA100 N-methyl- N`-nitro-nitroso-gaunidine represents an antimutagenic effect using in Table 2, wherein by using a 4-nitroquinoline1-oxide of jujube seed extract in S typhimurium TA100 mutations almonella The effect is shown in Table 3, and the indirect mutation effect using benzo (a) pyrene on Salmonella typhimurium TA98 in jujube ethanol extract is shown in Table 4, and the mutation inhibition effect of jujube was detected by Ames test. The mutagenicity was not found, and mutagenic effects were observed for the direct mutant N-methyl-N'-nitro-N-nitrosoguanidine and 4-nitro-quinoline-1-oxide and the indirect benzo (a) pyrene.

Treatment     Treatment Revertants/plateRevertants / plate Inhibition Inhibition
rate (%)rate (%)
SpontaneousSpontaneous 111111 MNNGMNNG 840.5840.5 MNNG+H MNNG + H 22 O ext.O ext. 10%             10% 327.5327.5 37.437.4 5%              5% 518518 44.244.2 2.5%            2.5% 567.5567.5 70.370.3

상기에서 MNNG(N-methyl-N'-nitro-nitrosoguanidine) 0.2㎍/plate이다.In the above, MNNG (N-methyl-N'-nitro-nitrosoguanidine) 0.2 µg / plate.

Treatment     Treatment Revertants/plateRevertants / plate Inhibition Inhibition
rate (%)rate (%)
SpontaneousSpontaneous 111111 MNNGMNNG 11561156 MNNG+H MNNG + H 22 O ext.O ext. 10%             10% 342342 77.977.9 5%              5% 523.5523.5 60.560.5 2.5%            2.5% 703.5703.5 43.343.3

상기에서 4-NQO (4-nitroquinoline-1-oxide) 0.1㎍/plate이다.In the above, 4-NQO (4-nitroquinoline-1-oxide) is 0.1 µg / plate.

Treatment     Treatment Revertants/plateRevertants / plate Inhibition Inhibition
rate (%)rate (%)
SpontaneousSpontaneous 38.538.5 MNNGMNNG 670670 MNNG+H MNNG + H 22 O ext.O ext. 10%             10% 150.5150.5 82.382.3 5%              5% 298.5298.5 58.858.8 2.5%            2.5% 593.5593.5 12.112.1

상기에서 Benzo(a)Pyrene 10㎍/plate이다.In the above, Benzo (a) Pyrene 10µg / plate.

(5) 암세포 증식 억제 효과 측정(5) measurement of cancer cell proliferation inhibitory effect

실험에 사용한 세포주는 사람의 간암세포 Hep G2(hepatoma cell, human)와 결장암 세포 HT-29(colon carcinoma cell, human)를 사용하였다. The cell lines used in the experiments were human hepatoma cells Hep G2 (hepatoma cell, human) and colon cancer cell HT-29 (colon carcinoma cell, human).

HT-29 cell은 RPMI-1640 배지에 10% FBS(10% heat inactivated fetal bovine serum)와 1% 항생제를 첨가하여 배양하였으며, HepG2 cell은 MEM 배지에 10% FBS와 1% 항생제를 첨가하여 배양하였다. 세포는 1회용 세포배양 plate (100㎠, corning)에서 단층으로 자라게 하였으며, 배양 온도 및 CO2 농도는 37℃, 5% CO2로 유지하여 적응시켜 배양하였으며 2~3일마다 계대 배양하면서 실험에 사용하였다.HT-29 cells were cultured with 10% FBS (10% heat inactivated fetal bovine serum) and 1% antibiotics in RPMI-1640 medium, and HepG2 cells were cultured with 10% FBS and 1% antibiotics in MEM medium. . The cells were grown in monolayers on a disposable cell culture plate (100㎠, corning), and the culture temperature and CO 2 concentration were maintained at 37 ° C. and 5% CO 2 for adaptation and cultured every two to three days. Used.

MTT assay는 세포의 생육 및 분화를 측정하는 colorimetric assay로서 살아있는 미토콘드리아 내 dehydrogenase 효소가 노란 수용성 물질인 MTT에 의해 dark blue formazan 생성을 기초로 하였다.The MTT assay is a colorimetric assay that measures the growth and differentiation of cells based on the production of dark blue formazan by MTT, a yellow water-soluble substance of dehydrogenase in living mitochondria.

대추 추출물들의 인간 간암세포 Hep G2(hepatoma cell, human)와 결장암 세포 HT-29(colon carcinoma cell, human)의 증식 억제 효과는 Green 등의 방법에 따라 MTT assay를 이용하여 검토하였다.The inhibitory effect of jujube extracts on the hepatoma cell Hep G2 (hepatoma cell, human) and colon cancer cell HT-29 (colon carcinoma cell, human) was investigated by MTT assay according to Green et al.

먼저 배양된 세포에서 배지를 제거한 다음 PBS를 첨가하여 가볍게 섞은 후 PBS를 다시 제거하고 0.25% trypsin-EDTA를 첨가하여 37℃에서 5분간 배양하여 세포가 culture dish의 바닥으로부터 완전히 분리되었는지 현미경으로 관찰한 후, 배양배지를 첨가하여 잘 혼합한 다음 세포 수를 1×105cells/㎖로 조정하여 실험에 사용하였다. 한편 시료는 각각 적당한 농도로 DMSO에 용해시켜 0.22㎛ membrane filter로 여과한 후 사용하였다. 96-well plate에 준비된 각 세포들을 198㎕씩 분주한 후 37℃, 5% CO2 하에서 24시간 배양하였다. 여기에 각 농도의 시료를 2㎕씩 첨가하여 48시간 동안 다시 배양한 후 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 0.5㎎/㎖)용액을 각각 첨가하여 MTT가 생존 암세포의 효소작용에 의해 환원되도록 하였다. 4시간 후 well 바닥에 형성된 formazan이 흩어지지 않게 조심스럽게 다루어 aspirator로 상층액을 제거하였다. 각 well에 DMSO 200㎕를 첨가하여 formazan이 용해되도록 한 후 microplate reader로 O.D. 540㎚에서 흡광도를 측정하였다. First, remove the medium from the cultured cells, mix lightly with PBS, remove PBS again, and incubate for 5 minutes at 37 ° C with 0.25% trypsin-EDTA to observe whether the cells were completely separated from the bottom of the culture dish. After the addition of the culture medium and mixed well, the cell number was adjusted to 1 × 10 5 cells / ㎖ was used in the experiment. Samples were dissolved in DMSO at the appropriate concentration and filtered through a 0.22㎛ membrane filter. Each cell prepared in a 96-well plate was dispensed 198 μl and incubated for 24 hours at 37 ℃, 5% CO 2 . 2 μl of each concentration sample was added thereto and incubated for 48 hours. Then, 3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide (MTT, 0.5 mg / ml) In addition, MTT was reduced by enzymatic action of viable cancer cells. After 4 hours, the formazan formed on the bottom of the well was carefully treated to remove the supernatant with an aspirator. 200 μl of DMSO was added to each well to dissolve formazan and the absorbance was measured at 540 nm using a microplate reader.

흡광도는 MTT가 세포에 의해 formazan으로 분해된 양을 나타내고 따라서 각 well의 viable cell 수와 비례하며 다음과 같이 cytotoxicity를 계산하여 세포 성장 저해 효과의 지표로 하였다.The absorbance represents the amount of MTT decomposed into cells by formazan. Therefore, the absorbance is proportional to the number of viable cells in each well, and cytotoxicity is calculated as follows.

본 발명의 대추 에탄올 추출물을 이용한 결장암세포 HT29 에서의 항암효과를 도 2에 나타내고, 대추 에탄올 추출물을 이용한 간암세포 HepG2 에서의 항암효과를 도 3에 나타낸다.The anticancer effect of colon cancer cell HT29 using jujube ethanol extract of the present invention is shown in Figure 2, and the anticancer effect of hepatic cancer cell HepG2 using jujube ethanol extract is shown in Figure 3.

대추에탄올 추출물들이 높은 암세포 증식억제 효과를 가짐을 도 2 및 도 3을 통해서 확인할 수 있다.Jujube ethanol extract has a high cancer cell proliferation inhibitory effect can be confirmed through 2 and 3.

도 1은 본 발명에 따른 비누를 나타내는 도면1 is a view showing a soap according to the present invention

도 2는 본 발명에 따른 대추씨 추출물의 항산화 효과를 나타내는 도면2 is a view showing the antioxidant effect of jujube seed extract according to the present invention

도 3 내지 도 4는 본 발명에 따른 대추씨 추출물의 항암 효과를 나타내는 도면3 to 4 is a view showing the anticancer effect of jujube seed extract according to the present invention

Claims (2)

삭제delete 대추씨의 분말시료에 5-15배의 99% 에탄올을 첨가한 후 환류 냉각기를 설치한 수욕상에서 5-10시간 동안 1-5회 반복 추출한 후 여과하고, 이 여액들을 감압 농축시킨는 대추씨 추출물 농축액 준비 단계와, After adding 5-15 times 99% ethanol to the jujube seed powder sample, the extract was repeated 1-5 times for 5-10 hours in a water bath equipped with a reflux condenser and filtered, and the filtrate was concentrated under reduced pressure. Preparation steps, 상기한 대추씨 추출물 농축액을 총중량의 0.5-10중량%가 되도록 첨가하여 비누를 제조하는 비누 제조단계로 구성되는 것을 특징으로 하는 비누 제조방법.Soap manufacturing method comprising a soap manufacturing step of adding the above jujube seed extract concentrate to 0.5-10% by weight of the total weight to prepare a soap.
KR1020080106031A 2008-10-28 2008-10-28 Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it KR101070382B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080106031A KR101070382B1 (en) 2008-10-28 2008-10-28 Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080106031A KR101070382B1 (en) 2008-10-28 2008-10-28 Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it

Publications (2)

Publication Number Publication Date
KR20100046968A KR20100046968A (en) 2010-05-07
KR101070382B1 true KR101070382B1 (en) 2011-10-05

Family

ID=42274150

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080106031A KR101070382B1 (en) 2008-10-28 2008-10-28 Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it

Country Status (1)

Country Link
KR (1) KR101070382B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101138157B1 (en) * 2010-12-02 2012-04-19 김미량 Natural soap and manufacturing thereof
CN106138284A (en) * 2015-03-27 2016-11-23 南京海恒医药科技有限公司 A kind of extraction process of Semen Ziziphi Spinosae effective site
WO2018097388A1 (en) * 2016-11-25 2018-05-31 (주)튜링겐코리아 Composition for skin whitening, wrinkle alleviation, antioxidation, and ultraviolet light blocking, containing jujube seed extract as active ingredient

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007297382A (en) * 2006-03-21 2007-11-15 Access Business Group Internatl Llc Method for reducing skin reaction

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007297382A (en) * 2006-03-21 2007-11-15 Access Business Group Internatl Llc Method for reducing skin reaction

Also Published As

Publication number Publication date
KR20100046968A (en) 2010-05-07

Similar Documents

Publication Publication Date Title
EP2327402B1 (en) Composition containing 4-o-methylhonokiol for treating or preventing amyloid- related diseases
KR101363111B1 (en) Pharmaceutical composition containing paddy husk and barley husk extract as activeingredient
KR101070382B1 (en) Soap containing the extracts of Zizyphus jujube seed and manufacturing method of it
KR101965061B1 (en) Composition for prevention or treatment of metabolic disorder comprising peanut sprout extracts and fractions thereof
KR101209574B1 (en) Pharmaceutical compositions and health functional foods compositions for the improvement of liver functions containing compound isolated from Youngia denticulata as an active ingredient
KR101954247B1 (en) Complex composition comprising green tea
JP5122147B2 (en) 2- (2-Methylpropanoyl) phloroglucinol-1,5-di-O-β-D-glucopyranoside having antioxidant activity
KR100614970B1 (en) Composition Comprising Defatted Perilla Extracted for Prevention and Attenuation of Cognitive Impairment
KR20180065419A (en) Composition for anti-inflammation with nipa fruticans wurmb
KR100733982B1 (en) Organic constituents of wood vinegar from Konara having the effects of cure and prevention of cancer, antibacterial and antioxidant
KR101864085B1 (en) Valproic acid derivatives, preparation method thereof and anticonvulsant comprising the same
JPH03240464A (en) Healthy food containing dioscorea japonica thumb extract
KR20200053370A (en) Composition for preventing or treating neurodegenerative disease comprising phlorotannin
JP5122148B2 (en) 2-Acylphloroglucinol-4,6-di-C-β-D-glucopyranoside having antioxidant activity
KR101449379B1 (en) Extraction method of lutein from green tea
KR20190136769A (en) Composition for antioxidant and anti-inflammatory comprising fraction of Ledum palustre L. extract as effective component
KR20030057911A (en) Drink Composition Containing Extracts of Gastrodia elata Blum
RU2717537C1 (en) Dietary supplement
KR101095013B1 (en) A composition isolated from Ishige okamurae extracts having cholinesterase inhibitory activity
KR101710276B1 (en) Composition for anti-diabete comprising ethanol extract of tuna heart
KR100775964B1 (en) Manufacturing process of saururus chinensis candy with antioxidant effect
KR20080082218A (en) Aceriphyllum rossii engler composition as a beta;-secretase inhibitor
KR20170087794A (en) Composition comprising the compounds for preventing or treating obesity or hyperlipidermia
KR101836801B1 (en) Composition comprising natural ingredients and having the activities imrpoving cognitive fuctions and traditional korean cookies having the composition
JP2012250932A (en) Anti-inflammatory composition and method for producing the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20140929

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20151228

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20170627

Year of fee payment: 6

R401 Registration of restoration
LAPS Lapse due to unpaid annual fee